Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.
Fouka E, Drakopanagiotakis F, Steiropoulos P.
Int J Mol Sci. 2024 May 12;25(10):5278. doi: 10.3390/ijms25105278.
PMID:38791316
Pulmonary manifestations of large, medium, and variable vessel vasculitis.
Adams TN, Zhang D, Batra K, Fitzgerald JE.
Respir Med. 2018 Dec;145:182-191. doi: 10.1016/j.rmed.2018.11.003. Epub 2018 Nov 10.
PMID:30509707
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Smith RM, Jones RB, Specks U, Bond S, Nodale M, Al-Jayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Ferraro A, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani R, McAlear C, Moreland LW, Mynard K, Nachman P, Pagnoux C, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Wroe C, Jayne D, Merkel PA; RITAZAREM co-investigators.
Ann Rheum Dis. 2023 Jul;82(7):937-944. doi: 10.1136/ard-2022-223559. Epub 2023 Mar 23.
PMID:36958796
Pulmonary vasculitis.
Casal A, Díaz-Garel J, Pereiro T, Toubes ME, Ricoy J, Valdés L.